(Q36639919)

English

Management of psychiatric disorders in children and adolescents with atypical antipsychotics: a systematic review of published clinical trials

scientific article published on 30 October 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

1 reference

Europe PubMed Central

Management of psychiatric disorders in children and adolescents with atypical antipsychotics: a systematic review of published clinical trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

2

object named as

Jan Buitelaar

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

author name string

Peter S Jensen

1

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Gahan J Pandina

3

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Carin Binder

4

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Magali Haas

5

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

publication date

30 October 2006

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

European Child & Adolescent Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

104-120

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Childhood-onset schizophrenia. A double-blind clozapine-haloperidol comparison

1 reference

https://api.crossref.org/works/10.1007%2FS00787-006-0580-1

21 January 2018

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00787-006-0580-1

21 January 2018

Growth and sexual maturation during long-term treatment with risperidone

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risperidone-associated diabetes mellitus in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Open trial of risperidone in 24 young children with pervasive developmental disorders.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risperidone in children with disruptive behavior disorders and subaverage intelligence: a 1-year, open-label study of 504 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risperidone treatment of children with autistic disorder: effectiveness, tolerability, and pharmacokinetic implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine: its impact on aggressive behavior among children and adolescents with schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind pilot study of risperidone in the treatment of conduct disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Pilot Study of Risperidone, Olanzapine, and Haloperidol in Psychotic Youth: A Double-Blind, Randomized, 8-Week Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A placebo-controlled trial of risperidone in Tourette syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hematological adverse events in clozapine-treated children and adolescents.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, double-blind, placebo-controlled study of risperidone maintenance treatment in children and adolescents with disruptive behavior disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperglycemia associated with the use of atypical antipsychotics.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Discontinuation of risperidone and reversibility of weight gain in children with disruptive behavior disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Typical and atypical antipsychotics in adolescent schizophrenia: efficacy, tolerability, and differential sensitivity to extrapyramidal symptoms

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated prolactin in pediatric patients on typical and atypical antipsychotics.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risperidone treatment in children and adolescents with autism: short- and long-term safety and effectiveness

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risperidone in the treatment of behavioral disturbances in children and adolescents with borderline intellectual functioning: a double-blind, placebo-controlled pilot trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Weight gain associated with atypical antipsychotic use in children and adolescents: prevalence, clinical relevance, and management

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Weight gain in adolescents treated with risperidone and conventional antipsychotics over six months

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measuring the parental, service and cost impacts of children with autistic spectrum disorder: a pilot study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Consensus development conference on antipsychotic drugs and obesity and diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Financial cost of social exclusion: follow up study of antisocial children into adulthood

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term, open-label study of risperidone in children with severe disruptive behaviors and below-average IQ.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risperidone treatment for juvenile bipolar disorder: a retrospective chart review

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroleptic-related dyskinesias in children and adolescents

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An open-label trial of risperidone in children and adolescents with bipolar disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olanzapine, risperidone and haloperidol in the treatment of adolescent patients with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psychiatric comorbidity, family dysfunction, and social impairment in referred youth with oppositional defiant disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of antipsychotic and prolactin concentrations in children and adolescents acutely treated with haloperidol, clozapine, or olanzapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term safety and efficacy of risperidone in children with disruptive behaviour disorders. Results of a 2-year extension study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Open-label treatment with risperidone of 26 psychiatrically-hospitalized children and adolescents with mixed diagnoses and aggressive behavior.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early-onset schizophrenia as a progressive-deteriorating developmental disorder: evidence from child psychiatry

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atypical antipsychotic drugs and hyperglycemia in adolescents

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Electrocardiographic changes in children and adolescents treated with ziprasidone: a prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risperidone in children with autism and serious behavioral problems

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 1-year open-label trial of olanzapine in school-age children with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A clinical case series of six extremely aggressive youths treated with olanzapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship of depressive, conduct, and comorbid disorders and social functioning in childhood.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age children

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolactin levels during long-term risperidone treatment in children and adolescents

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Open-label study of olanzapine in children with pervasive developmental disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): clinical implications and treatment practice suggestions

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Weight gain in a controlled study of risperidone in children, adolescents and adults with mental retardation and autism

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17075688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00787-006-0580-1

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36639919&oldid=2199127135"